Expat from Udupi killed in Saudi road mishap

Mysuru, Apr 7 Following a tiger at Bronx Zoo in the US, testing positive for COVID-19, Mysuru Zoo authorities here have taken measures to contain the spread of the dreaded disease as per the directions of the Central Zoo Authority (CZA).

The Zoo is on alert and the animal keepers are not allowed to enter the enclosures without safety gear. It is mandatory for the personnel to undergo thermal screening before entering the Zoo. The personnel are provided with safety gears such as masks, gloves and Sanitisers. The CZA has directed to spray disinfectants near the enclosures of the animals and has also directed to monitor the animals’ behavior.

Zoo Authority of Karnataka Member Secretary B P Ravi said, "COVID-19 was detected in a domestic cat two weeks back in Hong Kong. Due to the outbreak of bird flu in Mysuru, we have taken all precautionary measures to combat COVID-19."

New Delhi, Jul 3: The aviation regulator DGCA said on Friday it was extending the suspension of scheduled international passenger flights in the country till July 31 but added that some international scheduled services on selected routes may be permitted on a case to case basis.

Scheduled international passenger flights were suspended in India on March 23 due to the coronavirus pandemic.

Modifying its June 26 circular that stated that scheduled international passenger flights will remain suspended till July 15, 2020, the regulator stated on Friday it has decided to extend the deadline to July 31, 2020.

However, international scheduled flights may be allowed on selected routes by the competent authority on a case to case basis,” said the circular by the Directorate General of Civil Aviation (DGCA).

Air India and other private domestic airlines have been operating unscheduled international repatriation flights under the Vande Bharat Mission, which was started on May 6 by the Central government.

India resumed scheduled domestic passenger flights on May 25, after a gap of two months.

Tightening control over companies misleading advertisements of medicines and products, the Indian government could soon slap a fine of up to Rs10 lakh and up to two years' imprisonment. While repeat offender could be fined up to Rs50 and imprisonment up to five years.

The Ministry of Health and Family Welfare's new draft of the Drugs and Magic Remedies (Objectionable Advertisements) (Amendment) Bill, 2020, provides extremely stringent penalties compared to the current law.

Under the new Act, companies advertising medicines and products falsely claiming to make a person fairer, improve height and memory or cure issues like hair loss or greying and premature ageing, among several others, may attract more stringent fines and jail time.

The current Act, 1954, leaves scope for companies to create deceptive advertisements as first time offender can be jailed for six months while repeat offender can be up to one year in prison, reported The Indian Express.

Under the Bill, deceptive advertisements will cover digital advertising, notice, circular, label, wrapper, invoice, banner and poster, among others. The government also plans to expand the scope of the law under the proposed amendments to cover 24 more deceptive claims not included in the current law, like medicines that can cure AIDS, change the sex of a foetus, among others, reported Livemint.